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Terapi medis endometriosis hanya dapat digunakan dalam waktu yang terbatas karena timbul efek samping. Salah satu metode 
pengobatan yang dikembangkan untuk terapi medis tersebut adalah dengan menggunakan bahan-bahan herbal, antara lain kurkumin. 
Tujuan dari penelitian ini adalah untuk mempelajari konsentrasi AMH dalam serum dari model tikus endometriotik dengan 
suplementasi kurkumin. Penelitian eksperimental dilakukan pada laboratorium embriologi Fakultas Kedokteran Hewan Universitas 
Airlangga, Surabaya, Juli-Oktober 2011. Ini adalah tes laboratorium menggunakan 38 tikus betina (Rattus novergicus) yang tak sesuai 
kriteria inklusi. Untuk membuat model tikus endometriotik, masing-masing tikus disuntik dengan: A cyclosporin dan ethynil estradiol 
intramuskuler, jaringan endometrium manusia jinak intraperitoneal ovarium tumor. Model tikus endometriotik secara acak dibagi 
menjadi dua kelompok. Kelompok intervensi diberi kurkumin 24 mg (240 mg/kg) sekali sehari sampai empat belas hari. Tikus-tikus 
dikorbankan dan konsentrasi AMH dari serum diukur dengan alat tes ELISA kit dari Cusabio Biotech, Wuhan, Cina. Ada perbedaan 
yang signifikan pada konsentrasi serum AMH antara kurkumin kelompok (44.9 ± 20.1) kelompok plasebo (29.8 ± 11.9) (p <0.05). 
Sebagai kesimpulan, konsentrasi serum AMH lebih tinggi dalam model tikus endometriotik dengan suplementasi kurkumin. (MOG 
2011:19;96-101)  
  





Medical therapy of endometriosis can only be used within a limited time because of arising side effects. One method of medical 
treatment that was developed for this purpose is using herbal ingredients, the curcumin. The objective of this study was to study the 
AMH concentration in serum of endometriotic rat model with curcumin supplementation. This experimental study was performed at 
embryology laboratory Faculty of Veterinary Medicine of Airlangga University, Surabaya, July – October 2011. This was an 
experimental laboratory tests using 38 female rats (Rattus novergicus) with the inclusion criteria. To make endometriotic rat  model, 
each rat was injected with: both cyclosporin A and ethynil estradiol intramuscularly, human endometrial tissue of benign ovarian 
tumors intraperitoneally. The endometriotic rat model were randomly divided into two groups. The intervention group was comsuming 
curcumin 24 mg (240 mg/kg) once daily until fourteen days. The rats were sacrificed and the AMH concentration from serum were 
measured by ELISA kit assay from Cusabio Biotech, Wuhan, China. There was a significant difference in serum concentration of AMH 
between curcumin group (44.9 ± 20.1) an placebo group (29.8 ± 11.9) (p < 0.05). In conclusion, the concentration of serum AMH is 
higher in endometriotic rat models with curcumin supplementation. (MOG 2011:19;96-101)  
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Endometriosis is a disease that remains a problem for 
women of reproductive age. The prevalence in the general 
population of reproductive-age women between 3-10%.15 
Generally they are visiting a doctor with chief complaints 
of chronic pelvic pain, dysmenorrhoe, dyspareuni, and 
infertility. Data on dr.Soetomo Hospital Surabaya 
showed the incidence of endometriosis during 
laparoscopic procedure in patient with infertility, namely 
in 1987 and 1991 of 23.8%, in 1992 to 1993 increased to 
37.2%, and the last in 2002 reached 50%.  
There are several factors that cause high rates of infertility 
in patients with endometriosis, mechanical factors that 
cause adhesions of the reproductive organs and disrupt 
oocyte retrieval by fimbria during ovulation, another 
factors are defects of the immunological response and 
oocyte quality degradation due to interference 
folliculogenesis process. This decline in oocyte quality 
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will lead to low rates of pregnancy in women with 
endometriosis to less than 35% and the high incidence of 
abortion up to 27%.  
  
Defective immunological response characterized by an 
increase in the inflammatory process induced by the 
activity of macrophages in the peritoneal fluid, 
macrophages will secrete excessive number of cytokines 
including TNF-α. TNF-α will diffuse into the follicle, 
then through binding to its receptor (TNF-R1) on the 
membrane of granulosa cells, TNF-α activates the cell 
death signals and induce the occurrence of the caspase 
cascade and stimulate the process of apoptosis in 
granulosa cells. TNF-α also increases the production of 
ROS via the JNK-1 and will increase the oxidative stress 
that stimulates the process of granulosa cell apoptosis.1 
These pathological process of apoptosis will cause 
interference with the function of granulosa cells. Has 
been demonstrated in previous studies that the 
folliculogenesis process obtained cooperation between 
granulosa cells and oocyte cells.3 Both of these cells 
communicate with each other through paracrine pathways 
to produce good quality oocytes for fertilization, so that 
if an interruption occurs in granulosa cell function may 
result in decreased quality of oocytes and increased rates 
of infertility in patients with endometriosis.  
  
Commonly therapies used in endometriosis is by surgery 
or medically with hormonal medication or combination 
of both. The basic principle of therapy is to suppress 
symptoms and prevent progression to reduce 
endometriosis implants. Cure rate of surgical therapy 
about 80%, but surgery is too invasive and the number of 
recurency about 10%-20% and still require additional 
therapy. Some hormonal therapies currently used are to 
inhibit the growth of endometriosis implants by pressing 
the steroid hormone released by the ovaries and cause 
hipoestrogenik circumstances. Medical therapy of 
endometriosis can only be used within a limited time 
because of side effects arising hipoestrogen, so people 
expected on the new problem of infertility. The high 
recurrence rate reached 45% after completion of medical 
therapy is still an issue today.  
  
In line with the above conditions, the scientists tried to 
find new therapies with different molecular targets, has a 
high effectiveness and fewer side effects. One method of 
medical treatment that was developed for this purpose is 
using herbal ingredients that is curcumin. Curcumin is the 
active ingredient extracted from  
Curcuma longa, called turmeric in English and in 
Indonesian called kunir. Curcumin is known to suppress 
mutagenesis and used as a chemopreventive agent for 
various cancers such as colon, breast, prostate, 
esophagus, lung, and inhibiting atherosclerosis, inhibits 
the growth of viruses and bacteria. Curcumin also has 
anti-inflammatory effects through suppression of 
activation of nuclear factor-κB (NF-κB), anti-
proliferative effects through suppression of cyclin D1 and 
antiapoptotic gene product, induces release of 
cytochrome C and has the effect of anti-angiogenesis. 12 
and also known to have antioxidant effects.13  
  
In previous research has demonstrated that curcumin 
inhibited the growth of endometriosis cells via 
suppression of expression of VEGF (vascular endothelial 
growth factor) and a study by Johari8 has shown that 
curcumin can increase the number and maturation of ova 
in mice endometriosis model performed ovarian 
stimulation through suppression of inflammatory 
processes curcumin can suppress angiogenesis factor 
VEGF and widespread endo-metriosis implants in mice 
model of endometriosis is comparable with progestin 
(MPA).  
  
One marker that can be used to determine the function of 
granulosa cells was AMH (anti-Mullerian hormone) or 
MIS (müllerian inhibiting substance) which is a dimer 
glikoproterin included in the transforming growth factor-
beta (TGF-ß) superfamily. AMH in women is produced 
by the granulosa cells of pre-antral follicles and antral 
who played a role in folliculogenesis.16 AMH is secreted 
by the ovaries into the circulation so it can be measured 
in serum.   
  
The levels of serum AMH in patients with endometriosis 
has found decrease and proportional to the degree, the 
more severe the levels of AMH are also on the downside 
as well as on the levels of AMH in follicular fluid.3 AMH 
has advantages in describing the function of granulosa 
cells because it is not influenced by the menstrual cycle 
and use of contraceptive drugs, so it can be measured at 
each phase.   
  
AMH is a fairly good marker as a prognostic value in 
predicting number of mature oocytes obtained in an 
assisted reproductive technologies (ART) after 
gonadotropin stimulation. AMH even has a better 
prognostic value than other markers such as FSH, inhibin 
B, and estradiol. AMH serum level is important for 
predicting response to ovarian endometriosis in women 
who followed the ART program. Expected if obtained 
AMH levels are high then the success rate of ART 
program is also expected to rise.  
  
The following research proposes that granulosa cell 
apoptosis that occurs due to an increase in inflammatory 
factors in endometriosis will cause a decrease in AMH 
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levels. Expected with the administration of curcumin can 
inhibit inflammatory processes and apoptosis so as to 
suppress granulosa cell dysfunction characterized by high 
levels of AMH. With high levels of AMH are also 




MATERIALS AND METHODS  
  
Animals used in this researcg were 38 mature female rats 
(Rattus novergicus), weighing 100-150 g. Animals were 
kept in cages in a well environment and has adaptated for 
1 week. The fresh humans endometrial tissues was 
obtained from women undergoing elective hysterectomy 
for benign gynecological disease. The endometrial tissues 
then washed twice with phosphatebuffered saline (PBS) 
then suspended as coarse fragments in PBS with 200 
IU/ml of penicillin and 200 µg/ml of streptomycin. 
Endometrial tissues then injected intraperitoneally using 
16G neddle in rats. After injection of cyclosporin A and 
injection of estradiol on day 1 and day 5, the sampels then 
divided into two groups. Began the day-14 group A 
received curcumin per sonde during 14 days, while group 
B received placebo for 14 days per sonde. The rats then 
sacrificied at day 28 using high concentration of ether in 
a closed chamber.  
  
The AMH concentration from serum were measured by 
ELISA kit assay for rat from Cusabio Biotech, Wuhan, 
China. Absorbance was measured at wavelength 450 nm 
by using a multiplate reader. The AMH result was 
calculated using the standard curve with a base value of 
the manufacturer's standard assay kit (Cusabio Biotech), 
and data are presented as ng/ml. Statistical analysis was 
perform using SPSS program (version 19.0.1). Before 
statistical analysis, the data conducted 
KolgomorovSmirnov normality test. If the normality test 
results are normally distributed, then proceed with 
parametric statistical tests of comparison of the mean of 
two groups using independent two-sample t test.This 
study uses a significance level of 0.05.   
  
   
RESULTS AND DISCUSSION  
  
The weight variable are analyze using the test for 
normality of distribution by Kolmogorov-Smirnov test. 
The curcumin group obtained p  =  0.416 (before 
treatment) and p  =  0.712 (after treatment). Similarly, in 
the placebo group, p  =  0.787 obtained (before treatment) 
and p  =  0.711 (after treatment). Since p > 0.05 then the 
two groups of normally distributed. Because the 
distribution is normal, then performed independent two-
sample t test, and the obtained p> 0.05 in both groups so 
that it can be concluded that there was no significant 
differences. Similarly, the change in weight between the 
two groups, obtained p > 0.05, so no significant 
differences found in both groups and both groups are said 
to be homogeneous. Because the body weight of rats is 
homogeneous then the BB variables were not included in 
subsequent analysis.  
  
Variable levels of serum AMH Normality was tested 
using Kolmogorov-Smirnov one sample, where the 
obtained p  =  0.061 (p > 0.05), mean normal distribution. 
Because normally distributed, statistical tests used is 
parametric test using independent two-sample t test. Two-
sample t test results obtained p  =  0.008 (p  =  0.05) which 
means the average obtained significant differences 
between groups of AMH serum levels of curcumin and 
placebo groups.  
  
Endometriosis model made in rat does not fully represent 
the state of endometriosis in humans. But the 
endometrial-like lession resulting from the manufacture 
of this model is most similar to endometriosis cells in 
humans in terms of morphology and histopatology, so the 
state is considered to adequately represent the 
experimental model.  
  
Making a rat model of endometriosis performed by 
lowering the immune response function artificially, ie 
suppress lymphocyte proliferation and differentiation 
using cyclosporine A (an immunosuppressant). 
Furthermore, extracts of human endometrial cells injected 
into the abdominal cavity of mice. Inflammat-ory process 
is expected to occur due to the inclusion of foreign objects 
into the abdominal cavity of mice.  
  
This process will take about 3-6 days, then continued 
proliferation phase that aims to form granulation tissue. 
Intramusculus estrogen injection is used to enable the 
proliferation and growth of endometrial tissue in the 
abdominal cavity. Granulation tissue formation lasted 
until day 14, the process can continue until day 28. On 
day 14, treatment of curcumin and placebo on the rat 
model endometrosis begins. We did not conduct the 
confirmation incidence of endometriosis in macroscopic 
or histopathology specimens, therefore the success rate 
refers to the incidence of endometriosis is based on  
previous studies conducted by Kuswojo and Sa'adi.9   
  
In this study we have found that although a statistically 
significant difference in mean AMH levels in both 
groups, but we see that the results in each group is not 
uniform. In the curcumin group, we still get a sample with 
low levels of serum AMH, as well as in the placebo group, 
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we still get the serum AMH levels are quite high. This 
possibility can be explained by previous studies by 
Grummer et al.6 that it is influenced by the ability of rat 
model of recovery by itself. It is said that the ability of 
recovery varies between individuals and does not exceed 
the figure of 30%. This needs to be considered in 
analyzing the results of research, remember when we 
would do certain drug trials, because of differences in the 
number of lesions in both groups of experimental animals 
can be caused by differences in recovery at the beginning 
of the experiment compared the effects of the drugs 
tested. In this study, we divided rats randomly into 2 
groups: group by treatment with curcumin 
supplementation and one group with placebo 
supplementation treatment (NaCl fluid).   
  
It is therefore worth nothing that the study sample 
characteristics affect the results of the study, namely age 
and body weight of rats. We used female rats of the same 
age that is 3 months. At this age, rat are considered 
sexually mature so it is considered the same hormonal 
status. We did not do a vaginal smear to see the estrous 
cycles of rat when began the treatment or when taking a 
blood sample because it has been demonstrated by Aoki 
et al.2 that the growth of endometrial cells that 
transplanted into SCID mice is not affected by the estrous 
cycle of mice, thereby allowing endometrial tissue 
transplants done at all estrous cycle of rats. AMH levels 
in human are not influenced by the menstrual cycle and 
use of contraceptive drugs, so it can be measured at each 
phase of the menstrual cycle, therefore the measurement 
of serum AMH levels in rats in our research is also 
considered to be unaffected.  
  
Body weight of rats on our research about 100-150 grams. 
We measured body weight of rats at random. Body weight 
of rats we are testing with one sample Kolmogorov 
Smirnof, it obtained a normal distribution. After that we 
did a statistical analysis by independent two-sample t test 
and not found significant differences in body weight 
measurements before and after treatment as well as on 
changes in body weight in both groups (p> 0.05) so that 
the variable weight is homogeneous. In comparison there 
are few human studies that connecting between body 
mass index (BMI) and endometriosis. BMI in 366 women 
with endometriosis was lower than 268 women who 
underwent laparoscopy because of other minor 
gynecological problems. There is relationship between 
the degree of endometriosis with a BMI of women with 
endometriosis. In women with severe endometriosis 
degrees obtained a lower BMI compared with mild or 
moderate degree. We analogy there are similarities 
between the calculation of body weight of rats with BMI 
measurements in humans, so as a result we consider 
homogeneous then it is likely that the degree of 
endometriosis are positive in both groups was similar. 
Meanwhile, the study by Freeman et al.5 found that in 
women who are obese have a lower AMH levels than 
non-obese, because the weight of rats homogeneous, we 
consider the differences in levels of serum AMH in our 
research not affected by body weight of rats.  
  
Until now the method of treatment for endometriosis in 
humans is still not give encouraging results. One problem 
is the fear of side effects arising from such treatment, for 
example due to the effects of GnRH agonists 
hipoestrogenik or hiperandrogen effects on danazol 
administration. Thought that it tries to be developed is an 
attempt to discover new drugs that do not inhibit the 
hypothalamic-pituitary-ovarian, so people are not faced 
with infertility problems. One alternative that could be 
used is the use of curcumin herbal medium.  
  
A mixture of several drugs including curcumin has the 
same safety and efficacy compared gestrinone in the 
prevention of recurrence in patients with endometriosis 
post-surgery. One mechanism is believed to be the effect 
of curcumin here is the suppression of proinflammatory 
cytokines, inhibition of COX-2 and antioxidant effects.17   
  
Several studies have proven the cause of increased 
apoptosis in endometriosis is stimulated by increased pro-
inflammatory cytokines, including the widely studied is 
TNF-α. Found an increase in TNF-α in both the fluid and 
follicular fluid peritoneum. Research by Hendarto7 have 
elevated levels of TNF-α in the fluid peritoneum 
endometriosis women and the increase is in accordance 
with the degree of endometriosis. The higher the rank the 
levels of TNF-α is increasing. While the study by 
Falconer et al.4 found levels of TNF-α in follicular fluid 
of endometriosis women taller than women infertile due 
to tubal factor.  
  
Molecular mechanisms that could explain the 
involvement of TNF-α in the process of apoptosis is due 
to activation of one transcription factor NF-Κß is. Studies 
in vitro showed activation of NF-Κß in endometriosis 
stromal cells via the classical pathway of NF-Κß induced 
by IL-1. TNF-α or lipopolysaccharide.11 NF-Κß 
transcription factor known to play a role in the 
pathogenesis of endometriosis, which stimulate the 
process of adhesion, invasion, angiogenesis, 
inflammation, proliferation, and inhibits cell apoptosis 
endometriosis. The role of classical pathway activation of 
NF-Κß is a natural immune response that stimulates 
inflammation and maintain endometriosis lesions.11 
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Activation of transcription factor NF-Κß is also associated 
with increased ROS (Reactive Oxygen Species). There is 
an increase in ROS in the stromal and epithelial cells from 
endometriomas and endometrium of endometriosis 
women. ROS are the main ingredients of superoxide (O2-
) is converted to H2O2 by the enzyme SOD (super oxide 
dismutase), can further form hydroxyl Radicals (OH) ions 
due to the influence of H2O2 Fenton or Haber-Weiss 
reactions of O2. Hydroxyl Radicals have a short half-life 
and is much more reactive than superoxide. Schreck et al. 
(1991) proved H2O2 activates transcription factor NF-
ΚB. H2O2 causes the release of NF-ΚB binding to IκB.  
  
In several studies have demonstrated a decrease in both 
serum AMH levels in follicular fluid and endometriosis 
women. The study by Lemos et al.10  obtain serum levels 
of AMH in women endometriosis was lower than that of 
control women with infertility due to tubal factor (1.26 ± 
0.7 vs. 2.02 ± 0.72 with p  =  0.004). Research by Shebl14 
also show decreased levels of serum AMH in women 
endometriosis compared to controls (husband factors) 
and increases with the degree of endometriosis, in women 
with mild endometriosis obtained mean AMH levels do 
not differ from controls (3.28 ± 1.93 vs 3, 44 ± 2.06, p  =  
0.61) in women with severe degrees obtained mean AMH 
levels are significantly different (2.38 ± 1.83 vs. 3.58 ± 
2.46, p <0.0001).   
  
While the study by Falconer et al.4 find evidence of 
decreased levels of AMH in follicular fluid of 
endometriosis women. The mechanism of decrease in 
AMH levels has not been fully explained, this is likely to 
be influenced elevated levels of TNF-α in follicular fluid 
of endometriosis women, which ultimately induces an 
increase in the apoptotic process in granulosa cells. AMH 
levels decrease is probably caused by a reduced number 
of granulosa cells in cumulative result of an increase in 
the apoptotic process. However, this requires further 
research to prove it.  
  
In our study, mean AMH levels in the rat model of 
endometriosis curcumin group higher than the placebo 
group (44.9 ± 20.1 vs. 29.8 ± 11.9). Based on two samples 
independent t test found significant differences between 
the two groups (p  =  0.008). Difference in results is likely 
due to the success of curcumin in inhibiting the apoptotic 
process that occurs, as for the mechanism could be 
through multiple pathways including inhibition of 
activation of the transcription factor NF-Κß by a variety 
of consequences, suppression of inflammatory activity 
through the suppression of TNF-α directly or through 
antioxidant effect.   
  
Curcumin can inhibit the activation of the transcription 
factor NF-Κß to the target before the phosphorylation Ißa 
emphasis. Curcumin was shown to reduce negative 
impacts resulting from endometriosis patients with 
immune defects by anti TNF-α, anti-NF-Κß, antioxidant, 
anti-JNK and anti-caspase activation pathway. Curcumin 
can suppress NF-ΚB pathway and NF-ΚB target genes 
cytokines.  
  
Curcumin also has strong antioxidant capabilities. TNFα 
alone induces the formation of oxidative stress via JNK-
1 pathway that ultimately can induce apoptosis process.1 
Curcumin has anti-oxidant effect and this has been 
demonstrated in several studies. Curcumin inhibits 
formation of hydroxyl Radicals (OH) from Fenton 
reaction or Haber-Weiss by increasing the activity of 
antioxidants such as SOD, GPX, GSH, and GST. 
Similarly, the chain termination or chain addition of 
hydrogen on the phenolic structure of materials can 
catalyze hydrogen peroxide (H2O2) into H2O and O2. 
Curcumin is an antioxidant by breaking the chain of 
exogenous oxidants that inhibit lipid peroxidation.  
  
With inhibition of apoptosis that occurs will cause the 
number of granulosa cells that survived became higher so 
that proteins and hormones are secreted also higher. With 
more number of granulosa cells that survived the process 
of abnormal apoptosis, it is hoped will improve fertility 
in patients with endometriosis. This has been 
demonstrated in the study by Johari8, which found 
positive effects of supplementation of curcumin in mice 
model of endometriosis with the acquisition of 
fertilization success rates higher than placebo in terms of 
the number of ova and the ability of oocytes to complete 
the meiosis process. In the group given supplements of 
curcumin obtained a mean number of ova 15.42 ± 3.17 
compared with the placebo group the mean number of ova 
8.21 ± 2.82 (p  =  0.0001).   
  
These results may explain our study in which oocytes 
alleged role in the regulation of AMH by granulosa cells. 
The expression of AMH by granulosa cells is reduced 
when performed oositektomi and increased again when 
oocytes were cultured granulosa cells back together. The 
research studied the effect of curcumin on levels of AMH 
until now has not been reported. Our research has shown 
that the obtained serum AMH levels are higher in the 
group receiving curcumin supplementation, but further 
research needs to better understand the mechanisms 
underlying these findings.  
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CONCLUSION  
  
Serum AMH levels in rat model of endometriosis who 
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